Reversal of Dabigatran-Induced Anticoagulation
Dabigatran etexilate is a direct thrombin inhibitor widely used for stroke prevention in non-valvular atrial fibrillation and treatment of venous thromboembolism. While its predictable pharmacokinetics
Dabigatran etexilate is a direct thrombin inhibitor widely used for stroke prevention in non-valvular atrial fibrillation and treatment of venous thromboembolism. While its predictable pharmacokinetics
Apixaban is a direct oral anticoagulant (DOAC) that selectively inhibits factor Xa, thereby preventing thrombin generation and clot formation. It is commonly prescribed for stroke